NDMA

Update on Ranitidine/Zantac

As you may have read, the FDA recently released a warning regarding Ranitidine a medication frequently used for heartburn.  They reported that they found low levels of a carcinogenic impurity called NDMA (N-nitodimetylamine) in some ranitidine medications including the brand name version, Zantac.  Recently, this same impurity was found in other blood pressure medications that were recalled.

Pages

Subscribe to RSS - NDMA

DDAR Blog

3/11/20

 

The following is reprinted from the CCFA March 11, 2020 email blast to their provider network. 

We understand that there’s a lot of information in the news about the...

Latest News

3/11/20

Dear Patients

We are preparing like most of the other medical offices in the community to deal with a Coronavrus (COVID-19) threat.  We are currently calling all patients prior to their...